Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62,933,385
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
19,443,728
-
Shares change
-
-590,593
-
Total reported value, excl. options
-
$38,301,000
-
Value change
-
-$1,468,358
-
Number of buys
-
16
-
Number of sells
-
13
-
Price
-
$1.97
Institutional Holders of Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) as of Q3 2022
As of 30 Sep 2022 Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) had 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 19,443,728 shares of stock of the company.
Largest 10 holders included Laurion Capital Management LP, BVF INC/IL, CITADEL ADVISORS LLC, PERCEPTIVE ADVISORS LLC, TANG CAPITAL MANAGEMENT LLC, BARCLAYS PLC, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, Newtyn Management, LLC, and RA CAPITAL MANAGEMENT, L.P..
This table shows 41 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.